UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of the company's stock in a transaction dated Monday, July 21st. The stock was sold at an average price of $12.72, for a total transaction of $572,400.00. Following the completion of the transaction, the chief executive officer owned 4,923,376 shares in the company, valued at approximately $62,625,342.72. The trade was a 0.91% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Daniel Dines also recently made the following trade(s):
- On Friday, July 18th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.38, for a total transaction of $557,100.00.
- On Wednesday, July 16th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.43, for a total value of $559,350.00.
- On Wednesday, July 16th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.43, for a total value of $559,350.00.
- On Monday, July 14th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.44, for a total value of $559,800.00.
- On Friday, July 11th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.71, for a total value of $571,950.00.
- On Wednesday, July 9th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $13.17, for a total value of $592,650.00.
- On Monday, July 7th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $13.11, for a total value of $589,950.00.
- On Wednesday, July 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.54, for a total value of $564,300.00.
- On Monday, June 30th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total value of $575,100.00.
- On Friday, June 27th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total value of $575,100.00.
UiPath Trading Up 0.9%
UiPath stock traded up $0.12 during midday trading on Tuesday, reaching $12.57. 23,905,235 shares of the stock traded hands, compared to its average volume of 10,493,035. The company has a 50-day simple moving average of $12.75 and a two-hundred day simple moving average of $12.45. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93. The firm has a market cap of $6.72 billion, a PE ratio of -104.70, a price-to-earnings-growth ratio of 16.49 and a beta of 1.04.
UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The company had revenue of $356.62 million for the quarter, compared to analyst estimates of $332.17 million. During the same quarter last year, the company earned $0.13 EPS. UiPath's revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current year.
Analysts Set New Price Targets
PATH has been the subject of a number of recent research reports. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a research report on Friday, May 30th. Scotiabank boosted their price target on UiPath from $12.00 to $13.00 and gave the company a "sector perform" rating in a report on Friday, May 30th. Mizuho decreased their price target on UiPath from $12.00 to $11.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Truist Financial boosted their price target on UiPath from $12.00 to $13.00 and gave the company a "hold" rating in a report on Friday, May 30th. Finally, Canaccord Genuity Group set a $16.00 target price on UiPath and gave the stock a "buy" rating in a research note on Monday, June 2nd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, UiPath currently has a consensus rating of "Hold" and a consensus price target of $13.83.
Check Out Our Latest Research Report on UiPath
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Proficio Capital Partners LLC acquired a new position in shares of UiPath in the fourth quarter worth $307,000. Raymond James Financial Inc. acquired a new position in shares of UiPath in the fourth quarter worth $5,506,000. Corient Private Wealth LLC raised its holdings in shares of UiPath by 24.5% in the fourth quarter. Corient Private Wealth LLC now owns 17,133 shares of the company's stock worth $218,000 after acquiring an additional 3,374 shares during the last quarter. Thrivent Financial for Lutherans raised its holdings in shares of UiPath by 72.3% in the fourth quarter. Thrivent Financial for Lutherans now owns 35,970 shares of the company's stock worth $457,000 after acquiring an additional 15,089 shares during the last quarter. Finally, Xponance Inc. raised its holdings in shares of UiPath by 5.2% in the fourth quarter. Xponance Inc. now owns 53,192 shares of the company's stock worth $676,000 after acquiring an additional 2,630 shares during the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.
About UiPath
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.